Quantcast

Latest Regulus Therapeutics Stories

2014-02-20 16:25:50

LA JOLLA, Calif., Feb. 20, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-02-19 08:31:20

-RG-012 is an anti-miR Targeting microRNA-21 for the Treatment of Alport Syndrome, a Life-Threatening, Genetic Kidney Disease with No Approved Therapy- LA JOLLA, Calif., Feb.

2014-02-14 16:24:52

CARLSBAD, Calif., Feb. 14, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-02-13 08:30:40

-Martin Beaulieu, Ph.D. Brings Extensive Diagnostic Assay Development Experience- LA JOLLA, Calif., Feb.

2014-02-05 08:29:18

-Regulus to Develop microRNA-21 for Alport Syndrome, a Life-Threatening Orphan Kidney Disease, and microRNA-21 in Oncology, to Human Proof-of-Concept- LA JOLLA, Calif.,

2014-02-04 08:34:28

-Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience- LA JOLLA, Calif., Feb.

2014-02-03 16:25:26

LA JOLLA, Calif., Feb. 3, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-01-13 08:27:16

-Regulus microMarkers(TM) Designed to Support Regulus' Therapeutic Pipeline, its Collaborators and Strategic Partners- LA JOLLA, Calif., Jan.

2014-01-07 16:25:27

LA JOLLA, Calif., Jan. 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.


Word of the Day
aphotic
  • Having no light.
  • Of or relating to the region of a body of water that is not reached by sunlight and in which photosynthesis is unable to occur.
The word 'aphotic' comes from Greek roots meaning 'without' and 'light'.
Related